Volver
Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56261
Title: COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
Authors: 
Morales-Ortega, Alejandro
García de Tena, Jaime
Frutos-Pérez, Begoña
Jaenes-Barrios, Beatriz
Farfán-Sedano, Ana Isabel
Canales-Albendea, Miguel Ángel
Bernal-Bello, David
View more
Mesh: 
COVID-19
Hematologic Neoplasms
Humans
Protein Kinase Inhibitors
Risk Factors
SARS-CoV-2
View more
Issue Date: 15-Mar-2021
Citation: Cancer.2021;(127)11:1937-1938
PMID: 33721325
URI: https://hdl.handle.net/20.500.12530/56261
Rights: openAccess
Appears in Collections:Centros de Atención Primaria > Artículos

Files in This Item:
File SizeFormat 
PMC8250378.pdf72.7 kBAdobe PDFView/Open
Show full item record

Google Scholar ???export.bibtex.alt???


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.